Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

PHASE4TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients
Interventions
DRUG

cyclosporine micro-emulsion

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY